KLRA (KLRA) Insider Trading

Over the last 6 months, 0 institutions increased and 0 reduced their position (13F).

Insider Activity

Sentiment
50/100
Buys (3m)
0
Sells (3m)
0
Net (3m)
$0
ContextInstitutions accumulating (13F)
DateInsiderTypeSharesPrice
Jul 8, 2026Tregoning Kathleenofficer: See RemarksGrant175,000$23.30
Jun 11, 2026Renaud Ronald C JRdirector, officer: CEO & PresidentOption38,094$5.25
Apr 22, 2026RTW INVESTMENTS, LP10 percent ownerBuy500,000$16.00
Apr 20, 2026Bain Capital Life Sciences Investors, LLC10 percent ownerBuy1,562,500$16.00
Apr 20, 2026Kaplan Andrew T.director, 10 percent owner: Buy8,398,438$16.00
Apr 20, 2026Kaplan Andrew T.director, 10 percent owner: Grant38,300$16.00
Apr 20, 2026Cloghessy Paulaofficer: Chief People OfficerGrant60,000$16.00
Apr 20, 2026Akamine Scottofficer: Chief Legal OfficerGrant60,000$16.00
Apr 20, 2026Renaud Ronald C JRdirector, officer: CEO & PresidentGrant300,000$16.00
Apr 20, 2026Burgess Paul D.officer: See RemarksGrant100,000$16.00
Apr 20, 2026BAIN CAPITAL INVESTORS LLC10 percent ownerBuy8,398,438$16.00
Apr 20, 2026Coleman Jamie Bethofficer: Chief Commercial OfficerGrant75,000$16.00
Apr 20, 2026MACKAY MARTINdirectorGrant38,300$16.00
Apr 20, 2026Wasserman Scott M.officer: Chief Medical OfficerGrant100,000$16.00
Apr 20, 2026Hite ChristopherdirectorGrant38,300$16.00
Apr 20, 2026Clyburn FrankdirectorGrant38,300$16.00
Apr 20, 2026Pagan Douglas W.officer: Chief Financial OfficerGrant100,000$16.00
Apr 20, 2026MILLIGAN JOHN FdirectorGrant38,300$16.00
Apr 20, 2026Koppel Adamdirector, 10 percent owner: Buy1,562,500$16.00
Apr 20, 2026Koppel Adamdirector, 10 percent owner: Grant38,300$16.00

Source: KLRA SEC Form 4 filings, latest Jul 8, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their KLRA positions over the last 6 months (SEC Form 13F).

Increased
0
New positions
100
Reduced
0
Sold out
0
Largest moves
InstitutionActionSharesFiled
BAIN CAPITAL INVESTORS LLCNew Position26.3MAug 14, 2026
Bain Capital Life Sciences Investors, LLCNew Position22.6MAug 14, 2026
RTW INVESTMENTS, LPNew Position10.8MAug 14, 2026
CANADA PENSION PLAN INVESTMENT BOARDNew Position7.3MAug 14, 2026
Atlas Venture Life Science Advisors, LLCNew Position5.2MAug 13, 2026
FMR LLCNew Position4.0MAug 13, 2026
BlackRock, Inc.New Position3.9MAug 7, 2026
PRICE T ROWE ASSOCIATES INC /MD/New Position3.5MAug 14, 2026
CITADEL ADVISORS LLCNew Position3.2MSep 2, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.New Position3.2MAug 14, 2026
WELLINGTON MANAGEMENT GROUP LLPNew Position2.9MAug 14, 2026
Royalty Pharma Sub-Manager, LLCNew Position2.5MAug 21, 2026
Siren, L.L.C.New Position2.2MAug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1.7MAug 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position1.7MAug 13, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.